Search hospitals > Pennsylvania > Sayre
Guthrie Medical Group PC-Robert Packer Hospital
Claim this profileSayre, Pennsylvania 18840
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Adenocarcinoma
137 reported clinical trials
6 medical researchers
Summary
Guthrie Medical Group PC-Robert Packer Hospital is a medical facility located in Sayre, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Guthrie Medical Group PC-Robert Packer Hospital is involved with conducting 137 clinical trials across 242 conditions. There are 6 research doctors associated with this hospital, such as Joyson Poulose, Philip A. Lowry, Thomas J. Gergel, and Vineela Kasireddy.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Breast Cancer
Global LeaderER positive
Stage IV
HER2 negative
Top PIs
Joyson PouloseGuthrie Medical Group PC-Robert Packer Hospital4 years of reported clinical research
Studies Cancer
Studies Lung Cancer
21 reported clinical trials
60 drugs studied
Philip A. LowryGuthrie Medical Group PC-Robert Packer Hospital4 years of reported clinical research
Studies Lung Cancer
Studies Cancer
17 reported clinical trials
61 drugs studied
Thomas J. GergelGuthrie Medical Group PC-Robert Packer Hospital4 years of reported clinical research
Studies Lung Cancer
Studies Breast Cancer
6 reported clinical trials
20 drugs studied
Vineela KasireddyGuthrie Medical Group PC-Robert Packer Hospital4 years of reported clinical research
Studies Cancer
Studies Lung Cancer
3 reported clinical trials
4 drugs studied
Clinical Trials running at Guthrie Medical Group PC-Robert Packer Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Small Cell Lung Cancer
Skin Cancer
Pancreatic Cancer
Cutaneous Melanoma
Solid Tumors
Multiple Myeloma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Guthrie Medical Group PC-Robert Packer Hospital?
Guthrie Medical Group PC-Robert Packer Hospital is a medical facility located in Sayre, Pennsylvania. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Adenocarcinoma and other specialties. Guthrie Medical Group PC-Robert Packer Hospital is involved with conducting 137 clinical trials across 242 conditions. There are 6 research doctors associated with this hospital, such as Joyson Poulose, Philip A. Lowry, Thomas J. Gergel, and Vineela Kasireddy.